The topical application of antitumor agents for the treatment of diseases such as cutaneous cancer and psoriasis has many advantages; in particular, the systemic toxicity of the drug may be reduced. However, one of the problems in topical application of antitumor agents is the poor skin penetration of such compounds, e.g. mitomycin C (MMC).
One approach to improve the low skin penetrability of a drug is the use of a penetration enhancer to reduce the barrier function of the skin. Some compounds such as 2-pyrrolidone and decyl methyl sulfoxide have been reported as potential percutaneous penetration enhancers, and recently 1-dodecylazacycloheptan-2-one (Azone) has received considerable attention as a percutaneous absorption enhancer for a wide range of drugs.1 -3) Both the long alkyl chain moiety and the mild polar ring moiety of Azone seem to be necessary for its action as a penetration promoter.
In the previous report, four types of percutaneous absorption enhancers with azacyclo ring moieties and terpene chains were designed. Some of these substances improved the percutaneous penetration of MMC through the skin of hairless mouse and rat, and were almost equipotent to Azone in this regard.4) In the present study, five new compounds with different structural characteristics were designed and their effects on the percutaneous penetration of MMC through the rat skin were investigated. 
Results and Discussion
The structures of enhancers examined in this investigation are shown in Fig. 1 . Saturation of the side chain of 7FU yields the structure of 7FS, which can be considered as Azone methylated at three positions in its alkyl chain. Similarly, saturation of the side chain of 1-geranylazacycloheptan-2-one (7GU) (reported in previous paper) gives 7GS. All these 
